Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses (NCT06171607)
Characterizing Breast Masses Using an Integrative Framework of Machine Learning and Radiomics
🩺 Plain-English Summary (8th-Grade Level)
This clinical trial investigates the role of contrast enhanced ultrasound (CEUS) in identifying cystic breast masses as benign or malignant. Ultrasound is a diagnostic imaging test that uses sound waves to make pictures of the body without using radiation (x-rays). Ultrasounds are widely used to diagnose many diseases in the body. This trial may help researchers learn if using CEUS will help in determining whether or not an ultrasound guided biopsy is necessary.
Who can join: Review the eligibility criteria below.
Location: Los Angeles County-USC Medical Center — Los Angeles, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Los Angeles County-USC Medical Center — Los Angeles, California
- USC / Norris Comprehensive Cancer Center — Los Angeles, California
📞 Contact the Study Coordinator
Phone: (323) 865-3205
Email: Janet.jaime@med.usc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Breast Carcinoma
- Mobile Health for Adherence in Breast Cancer Patients — Fairbanks, Alaska
- An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients With Breast Cancer Undergoing Breast Reconstruction — Houston, Texas
- Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer — Houston, Texas
- HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics — Duarte, California
- A Digital Health Intervention to Improve Symptoms and Physical Activity During Breast Radiation — Seattle, Washington
- Breast Cancer WEight Loss Study (BWEL Study) — Daphne, Alabama
Explore by condition: All Breast Carcinoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.